Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2018 5
2019 2
2020 7
2021 3
2022 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab in the management of metastatic melanoma.
Spain L, Younger E, Hatipoglu E, Larkin J. Spain L, et al. Among authors: younger e. Melanoma Manag. 2015 Nov;2(4):315-325. doi: 10.2217/mmt.15.33. Epub 2015 Nov 12. Melanoma Manag. 2015. PMID: 30190860 Free PMC article. Review.
Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: A systematic review.
Roets E, van der Graaf W, van Riet BHG, Haas RL, Younger E, Sparano F, Wilson R, van der Mierden S, Steeghs N, Efficace F, Husson O. Roets E, et al. Among authors: younger e. Crit Rev Oncol Hematol. 2024 May;197:104345. doi: 10.1016/j.critrevonc.2024.104345. Epub 2024 Apr 4. Crit Rev Oncol Hematol. 2024. PMID: 38582227 Free article. Review.
Young adults: a unique group in cancer epidemiological research.
Husson O, Lidington E, Younger E, van der Graaf WT. Husson O, et al. Among authors: younger e. Lancet Oncol. 2018 Feb;19(2):e72. doi: 10.1016/S1470-2045(18)30029-9. Lancet Oncol. 2018. PMID: 29413473 No abstract available.
Development of a Disease-Specific Health-Related Quality of Life Questionnaire (DTF-QoL) for Patients with Desmoid-Type Fibromatosis.
Schut AW, Lidington E, Timbergen MJM, Younger E, van der Graaf WTA, van Houdt WJ, Bonenkamp JJ, Jones RL, Grünhagen DJ, Sleijfer S, Verhoef C, Gennatas S, Husson O. Schut AW, et al. Among authors: younger e. Cancers (Basel). 2022 Jan 29;14(3):709. doi: 10.3390/cancers14030709. Cancers (Basel). 2022. PMID: 35158976 Free PMC article.
Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers.
Smrke A, Younger E, Wilson R, Husson O, Farag S, Merry E, Macklin-Doherty A, Cojocaru E, Arthur A, Benson C, Miah AB, Zaidi S, Gennatas S, Jones RL. Smrke A, et al. Among authors: younger e. JCO Glob Oncol. 2020 Jul;6:1046-1051. doi: 10.1200/GO.20.00220. JCO Glob Oncol. 2020. PMID: 32639877 Free PMC article.
Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation.
Lidington E, Hogan H, Gandolfi A, Lawrence J, Younger E, Cho H, Peckitt C, Mohammed K, Matharu S, Scerri L, Husson O, Cruickshank S, Turner R, Wedlake L. Lidington E, et al. Among authors: younger e. J Patient Rep Outcomes. 2022 Dec 22;6(1):128. doi: 10.1186/s41687-022-00529-9. J Patient Rep Outcomes. 2022. PMID: 36547735 Free PMC article.
21 results